Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to compare adhesion prophylaxis with polylactide-caprolactone-trimethylenecarbonate copolymer to icodextrin 4% in terms of safety, side effects and usability in addition to gaining early evidence of the effectiveness of polylactide-caprolactone-trimethylenecarbonate copolymer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 9, 2008
CompletedFirst Posted
Study publicly available on registry
January 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedJune 10, 2008
June 1, 2008
3 months
January 9, 2008
June 9, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in visual analogue pain score on visit 8 after discharge minus visit 1 on admission
3 months
Secondary Outcomes (11)
Use of analgesia
1, 2 and 3 days
Post-operative pyrexia
3 months
Post-operative infection
3 months
Requirement for re-operation
3 months
Dysmenorrhoea
3 months
- +6 more secondary outcomes
Study Arms (2)
1
EXPERIMENTAL2
ACTIVE COMPARATORInterventions
Polylactide-caprolactone-trimethylenecarbonate copolymer membrane is applied directly over the surgical scar on the visceral peritoneum
1 liter icodextrin 4% is instilled into the peritoneal cavity at the end of the operation
Eligibility Criteria
You may qualify if:
- age 18-60 years
- sex female
- laparoscopic myomectomy indicated
- ability and intention to conform to the study protocol
- written informed consent
You may not qualify if:
- pregnancy
- indication for laparotomy
- inflammatory bowel disease
- additional surgical interventions
- known or suspected intollerance or hypersensibility to the interventions
- chronic pain
- systemic corticoids or irradiation
- alcohol abuse or other substance abuse
- clinical signs of malignancy
- psychiatric or neurological disease
- participation in another clinical trial within 30 days
- inability to understand the purpose of the trial or to conform to the study protocol
- absence of written informed consent
- inflammation of pelvic organs
- presence of adhesions which lead to a conversion from laparoscopy to laparotomy
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitäts-Frauenklinik Tübingen
Tübingen, Baden-Wurttemberg, 72076, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Diethelm Wallwiener, Prof. Dr.
Universitäts-Frauenklinik Tübingen
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 9, 2008
First Posted
January 18, 2008
Study Start
January 1, 2008
Primary Completion
April 1, 2008
Last Updated
June 10, 2008
Record last verified: 2008-06